[go: up one dir, main page]

AR101185A1 - Anticuerpos anti-factor v o factor v activado - Google Patents

Anticuerpos anti-factor v o factor v activado

Info

Publication number
AR101185A1
AR101185A1 ARP150102212A ARP150102212A AR101185A1 AR 101185 A1 AR101185 A1 AR 101185A1 AR P150102212 A ARP150102212 A AR P150102212A AR P150102212 A ARP150102212 A AR P150102212A AR 101185 A1 AR101185 A1 AR 101185A1
Authority
AR
Argentina
Prior art keywords
seq
factor
fva
variable regions
activated antibodies
Prior art date
Application number
ARP150102212A
Other languages
English (en)
Original Assignee
Novo Nordiks As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordiks As filed Critical Novo Nordiks As
Publication of AR101185A1 publication Critical patent/AR101185A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75Agonist effect on antigen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente solicitud se relaciona con anticuerpos monoclonales o fragmentos de estos, que específicamente se unen al Factor V activado (FVa), que despliegan un efecto pro-coagulante y usos terapéuticos de estos. Reivindicación 10: Un anticuerpo monoclonal anti-FVa o un fragmento de este de unión al antígeno, donde las CDR de las regiones variables de cadena ligera y pesada son como en las regiones variables definidas por la SEQ ID Nº 1 y SEQ ID Nº 2, SEQ ID Nº 3 y SEQ ID Nº 4, SEQ ID Nº 5 y SEQ ID Nº 6, SEQ ID Nº 7 y SEQ ID Nº 8, SEQ ID Nº 9 y SEQ ID Nº 10, SEQ ID Nº 11 y SEQ ID Nº 12, SEQ ID Nº 13 y SEQ ID Nº 14, SEQ ID Nº 15 y SEQ ID Nº 16, SEQ ID Nº 17 y SEQ ID Nº 18, SEQ ID Nº 19 y SEQ ID Nº 20, SEQ ID Nº 21 y SEQ ID Nº 22, SEQ ID Nº 23 y SEQ ID Nº 24, SEQ ID Nº 25 y SEQ ID Nº 26, SEQ ID Nº 27 y SEQ ID Nº 28, SEQ ID Nº 29 y SEQ ID Nº 30, SEQ ID Nº 31 y SEQ ID Nº 32, SEQ ID Nº 33 y SEQ ID Nº 34, SEQ ID Nº 39 y SEQ ID Nº 40, SEQ ID Nº 41 y SEQ ID Nº 42, SEQ ID Nº 43 y SEQ ID Nº 44.
ARP150102212A 2014-07-11 2015-07-10 Anticuerpos anti-factor v o factor v activado AR101185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14176717 2014-07-11

Publications (1)

Publication Number Publication Date
AR101185A1 true AR101185A1 (es) 2016-11-30

Family

ID=51162604

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102212A AR101185A1 (es) 2014-07-11 2015-07-10 Anticuerpos anti-factor v o factor v activado

Country Status (3)

Country Link
AR (1) AR101185A1 (es)
TW (1) TW201617371A (es)
WO (1) WO2016005564A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019071116A1 (en) * 2017-10-05 2019-04-11 Epivax, Inc. T REGULATORY LYMPHOCYTE EPITOPES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT807691E (pt) * 1994-02-14 2002-04-29 Univ Leiden Metodo para a pesquisa quanto a presenca de um defeito genetico associado a trombose e/ou fraca resposta anticoagulante a proteina c activada
US20060014934A1 (en) * 2004-05-18 2006-01-19 Everse Stephen J Crystal structure of factor Vai and method for identifying blood factor Va modulators
US8236764B2 (en) * 2006-02-23 2012-08-07 The Children's Hospital Of Philadelphia Methods for treating a hemostasis related disorder using activated forms of Factor V
CA2666905A1 (en) * 2006-10-16 2008-06-05 Novelmed Therapeutics, Inc. Method of inhibiting coagulation with human anti-factor va antibodies and use thereof

Also Published As

Publication number Publication date
WO2016005564A3 (en) 2016-04-07
WO2016005564A2 (en) 2016-01-14
TW201617371A (zh) 2016-05-16

Similar Documents

Publication Publication Date Title
EA201791961A1 (ru) Антитела, специфичные к cd47 и pd-l1
PH12021550023A1 (en) Humanized anti-tau antibodies
PE20190737A1 (es) Anticuerpos anti-cd27
EA201690167A1 (ru) Гуманизованные или химерные антитела к cd3
MX366359B (es) Anticuerpos humanizados contra la molecula de adhesion celular relacionada al antigeno carcinoembrionico 1 (ceacam1).
PE20151289A1 (es) Anticuerpos que se unen al tl1a y sus usos
NI201700018A (es) Anticuerpos anti-lag3 y fragmentos de unión a antígeno
EA201792589A1 (ru) Антитела против cd123 и конъюгаты указанных антител
EA201890305A1 (ru) Гуманизированные или химерные cd3-антитела
EA201890285A1 (ru) Антитела против pd-1, активируемые антитела против pd-1 и способы их применения
CR20190009A (es) Anticuerpos anti-pd-1, un método de producción y un método para su uso.
MX2018008934A (es) Anticuerpos anti-ror1, anticuerpos biespecíficos ror1 x cd3 y métodos para su uso.
MX353278B (es) Raton con cadena ligera comun.
AR102239A1 (es) Anticuerpos anti-ox40 humanizados y sus usos
PE20160690A1 (es) Anticuerpos anti-cd134 (ox40) humanizados y usos de los mismos
CO2019013669A2 (es) Anticuerpos anti-garp-tgf-β
EA201791527A1 (ru) Биспецифические антитела против плазменного калликреина и фактора xii
AR105267A1 (es) Anticuerpos de unión a tau
CO2019007686A2 (es) Anticuerpos anti-properdina monovalentes y fragmentos de anticuerpo
EA201990894A1 (ru) Анти-pd-1/анти-her2 гетеродимерное биспецифическое антитело со структурой природного антитела и способ его получения
EA201892225A1 (ru) АНТИТЕЛА К ФАКТОРУ Bb КОМПЛЕМЕНТА И ИХ ПРИМЕНЕНИЕ
EA201890340A1 (ru) Моноклональное антитело-ингибитор фактора xiia
CO2017004753A2 (es) Anticuerpos que se unen a ccr6
PE20161404A1 (es) Anticuerpos ang2
PH12015501650A1 (en) Human antibody specific to human metapneumovirus, or antigen-binding fragment thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure